Multi-targeted and aggressive treatment of patients with type 2 diabetes at high risk: What are we waiting for?

Keyphrases

• High Risk 100%
• Aggressive Treatment 100%
• Type 2 Diabetic Patients 100%
• Targeted Treatment 100%
• Treatment Barriers 100%
• Intervention Studies 50%
• Success Criteria 50%
• Treatment Algorithm 50%
• Risk Factors 50%
• Type 2 Diabetes Mellitus (T2DM) 50%
• Steno 50%
• Health Benefits 50%
• Caregivers 50%
• Hypertension 50%
• Pro-inflammation 50%
• Relative Risk 50%
• Dyslipidemia 50%
• Insulin Resistance 50%
• Age Groups 50%
• Cardiovascular Risk 50%
• Motivation 50%
• Smoking Habits 50%
• All Ages 50%
• Dietary Habits 50%
• Polypharmacy 50%
• Sedentary Behavior 50%
• Community-based 50%
• High-risk Types 50%
• Controlled Experiment 50%
• Postgraduate Training 50%
• Microangiopathy 50%
• Continuous Education 50%
• Troubleshooting 50%
• High Time 50%

Medicine and Dentistry

• Diabetes 100%
• Maturity Onset Diabetes of the Young 100%
• Diabetes Mellitus 100%
• Microangiopathy 100%
• Patient with Type 2 Diabetes 100%
• Insulin Resistance 100%
• Dyslipidemia 100%
• Intervention Trial 100%
• Cardiovascular Risk 100%
• Controlled Clinical Trial 100%
• Polypharmacy 100%
• Dietary Habit 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Inflammation 50%
• Diabetes Mellitus 50%
• Intervention Trial 50%
• Cardiovascular Risk 50%
• Controlled Clinical Trial 50%
• Polypharmacy 50%
• Dyslipidemia 50%
• Insulin Resistance 50%
• Microangiopathy 50%